Table of Contents
<< Previous Issue | Dec 2011 (Vol: 2011, Issue: 12) | Next Issue >> |
- Section: Cartoons
-
Stress
- Section: Joint Venture
-
Biogen Idec Enters Biosimilars Market via Joint Venture with Samsung Biologics
- Section: Licensing
-
Servier Options MacroGenics’ Phase I Cancer Immunotherapy
- Section: Mergers & Acquisitions
-
India’s Lupin Expands its Presence In Japan with I’rom Pharmaceutical Acquisition
-
Gilead Bets on Pharmasset with US$11 B Acquisition Agreement
-
Pfizer Gains Phase II Skin Fibrosis Drug with Excaliard Acquisition
-
AstraZeneca Strengthens its Position in China with Guangdong BeiKang Pharmaceutical Acquisition
- Section: Research & Development
-
Roche Forays in Rare Diseases by Licensing PTC Therapeutics’ Spinal Muscular Atrophy Programme